BridgeBio Oncology Therapeutics Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| CORMORANT ASSET MANAGEMENT, LP | 02/17/2026 | 17.88 M | $223.84 M | 0.00% | 76.05% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 02/17/2026 | 4.89 M | $61.17 M | 0.00% | 20.78% |
| OMEGA FUND MANAGEMENT, LLC | 02/17/2026 | 3.29 M | $41.19 M | 0.00% | 13.99% |
| WELLINGTON MANAGEMENT GROUP LLP | 02/17/2026 | 2.91 M | $36.40 M | -1.83% | 12.37% |
| ECOR1 CAPITAL, LLC | 02/17/2026 | 2.82 M | $35.35 M | 0.00% | 12.01% |
| ALPHABET INC. | 02/13/2026 | 2.82 M | $35.35 M | 0.00% | 12.01% |
| ENAVATE SCIENCES GP, LLC | 02/17/2026 | 2.63 M | $32.89 M | 0.00% | 11.17% |
| CITADEL ADVISORS LLC | 02/17/2026 | 2.53 M | $31.68 M | -0.31% | 10.76% |
| PARADIGM BIOCAPITAL ADVISORS LP | 02/17/2026 | 2.26 M | $28.32 M | 21.20% | 9.62% |
| BLACKROCK, INC. | 02/12/2026 | 2.08 M | $26.10 M | 1.77% | 8.87% |
| NOVO HOLDINGS A/S | 02/17/2026 | 1.96 M | $24.56 M | 0.00% | 8.34% |
| LAURION CAPITAL MANAGEMENT LP | 02/17/2026 | 1.46 M | $18.34 M | 40.08% | 6.23% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 02/17/2026 | 1.40 M | $17.53 M | -5.89% | 5.96% |
| EVENTIDE ASSET MANAGEMENT, LLC | 02/13/2026 | 1.08 M | $13.39 M | 0.00% | 4.60% |
| OCTAGON CAPITAL ADVISORS LP | 02/17/2026 | 1.04 M | $13.06 M | 0.00% | 4.44% |
| ARMISTICE CAPITAL, LLC | 02/17/2026 | 1.00 M | $12.52 M | 142.72% | 4.25% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 02/17/2026 | 803.13 K | $10.06 M | -9.25% | 3.42% |
| VANGUARD GROUP INC | 01/29/2026 | 791.10 K | $9.90 M | 22.16% | 3.37% |
| AISLING CAPITAL MANAGEMENT LP | 02/10/2026 | 564.63 K | $7.07 M | 0.00% | 2.40% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 561.99 K | $7.04 M | 3.76% | 2.39% |
| CATALIO CAPITAL MANAGEMENT, LP | 02/17/2026 | 410.70 K | $31.41 M | 100.00% | 1.75% |
| CASDIN CAPITAL, LLC | 02/17/2026 | 282.31 K | $3.53 M | 0.00% | 1.20% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/13/2026 | 279.05 K | $3.49 M | -0.11% | 1.19% |
| MILLENNIUM MANAGEMENT LLC | 02/17/2026 | 241.42 K | $3.02 M | -34.68% | 1.03% |
| FMR LLC | 02/17/2026 | 240.30 K | $3.01 M | 48.26% | 1.02% |
| HIGHVISTA STRATEGIES LLC | 02/17/2026 | 229.26 K | $2.87 M | 100.00% | 0.98% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 02/18/2026 | 226.25 K | $2.83 M | -54.86% | 0.96% |
| IKARIAN CAPITAL, LLC | 02/18/2026 | 220.23 K | $2.76 M | -10.19% | 0.94% |
| STATE STREET CORP | 02/13/2026 | 218.28 K | $2.73 M | 23.53% | 0.93% |
| SIO CAPITAL MANAGEMENT, LLC | 02/17/2026 | 130.63 K | $1.64 M | 0.00% | 0.56% |
| TD ASSET MANAGEMENT INC | 02/10/2026 | 117.15 K | $1.47 M | -9.93% | 0.50% |
| WOODLINE PARTNERS LP | 02/17/2026 | 103.71 K | $1.30 M | 0.00% | 0.44% |
| MOORE CAPITAL MANAGEMENT, LP | 02/17/2026 | 100.00 K | $1.25 M | 0.00% | 0.43% |
| GOLDMAN SACHS GROUP INC | 03/25/2026 | 94.65 K | $1.19 M | 100.00% | 0.40% |
| UBS GROUP AG | 01/29/2026 | 93.37 K | $1.17 M | 78.78% | 0.40% |
| STEMPOINT CAPITAL LP | 02/17/2026 | 86.52 K | $1.08 M | -53.64% | 0.37% |
| RENAISSANCE TECHNOLOGIES LLC | 02/12/2026 | 74.30 K | $930.24 K | 100.00% | 0.32% |
| BOOTHBAY FUND MANAGEMENT, LLC | 02/17/2026 | 67.03 K | $839.27 K | -30.57% | 0.29% |
| NORTHERN TRUST CORP | 02/17/2026 | 58.03 K | $726.59 K | -39.52% | 0.25% |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 02/13/2026 | 54.19 K | $670.36 K | 100.00% | 0.23% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 02/17/2026 | 35.95 K | $450.12 K | 100.00% | 0.15% |
| XTX TOPCO LTD | 02/17/2026 | 28.63 K | $358.49 K | 22.45% | 0.12% |
| BNP PARIBAS ARBITRAGE, SNC | 02/10/2026 | 26.47 K | $331.43 K | 100.00% | 0.11% |
| BIT CAPITAL GMBH | 02/11/2026 | 25.00 K | $313.00 K | 100.00% | 0.11% |
| POINT72 ASSET MANAGEMENT, L.P. | 02/17/2026 | 23.58 K | $295.27 K | 100.00% | 0.10% |
| MORGAN STANLEY | 02/13/2026 | 14.35 K | $179.69 K | 1,566.90% | 0.06% |
| QUADRATURE CAPITAL LTD | 02/17/2026 | 12.92 K | $161.78 K | 100.00% | 0.06% |
| SQUAREPOINT OPS LLC | 02/13/2026 | 11.52 K | $144.17 K | 100.00% | 0.05% |
| PERSISTENT ASSET PARTNERS LTD | 02/17/2026 | 8.59 K | $107.48 K | 100.00% | 0.04% |
| CIBC PRIVATE WEALTH GROUP, LLC | 02/12/2026 | 5.00 K | $62.60 K | 100.00% | 0.02% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
BridgeBio Oncology Therapeutics Inc. institutional Ownership - FAQ's
During the previous two years, 63 institutional investors and hedge funds held shares of BridgeBio Oncology Therapeutics Inc.. The most heavily invested institutionals were:
Alphabet Inc.: 2.82 M
Aisling Capital Management LP: 1.02 M
ROYCE & ASSOCIATES LP: 636,522
VANGUARD FIDUCIARY TRUST CO: 254,329
BNP PARIBAS ARBITRAGE, SNC: 90,819
TEMA ETFS LLC: 82,172
248.02% of BridgeBio Oncology Therapeutics Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 59.83 M shares in the last 24 months. This purchase volume represents approximately $616.87 M in transactions.